Industry Focus

What Gilead Sciences and Sangamo Therapeutics disappointing data means to investors and why Allergan may face a formidable foe in up-and-comer Evolus. Stocks: GILD, SGMO, AGN, EOLS

Direct download: IF_healthcare_02132019_podcast_v2.mp3
Category:Podcast -- posted at: 3:30pm EST